Basic Information


GTO ID GTC0739
Trial ID ChiCTR1800016340
Disease Malignant Tumor
Altered gene MESO
Therapeutic/Target gene Target gene
TherapyCAR-T cell
Treatment MESO CAR-T cells
PhaseEarly_Phase1
Recruitment statusNot Recruiting
TitleThe clinical study of chimeric antigen receptor gene-modified autologous T cells targeting mesothelin for advanced malignant tumors
Year2018
CountryChina
Company sponsorShanghai Jiao Tong University Affiliated Sixth People's Hospital

Clinical Result

Cohort 1
Administration route None
Pts 20

Relationship Graph

Overview of Knowledge Graph